Semaglutide
A GLP-1 receptor agonist commonly evaluated for medical weight management and metabolic support.
Every listing is educational. A licensed provider decides suitability, dosing, and monitoring during a live consultation.
A GLP-1 receptor agonist commonly evaluated for medical weight management and metabolic support.
Dual GIP/GLP-1 receptor agonist evaluated for weight and cardiometabolic health.
GHRH analog studied for stimulation of the body's own growth hormone.
GHRH and GHRP combination studied for pulsatile growth hormone release.
GHRH analog with FDA approval for a specific HIV-related indication; sometimes discussed off-label.
Peptide fragment studied primarily in preclinical models for tissue repair.
Copper-binding tripeptide studied for skin and hair follicle signaling.
Coenzyme central to cellular energy, sirtuin activation, and DNA-repair pathways.
Endogenous tripeptide antioxidant used clinically in select settings.
Melanocortin receptor agonist with an FDA-approved indication in premenopausal women; other uses discussed with providers.
Neuroendocrine peptide studied in hypothalamic-pituitary-gonadal signaling.
Immunomodulatory peptide studied for T-cell function.
Modified GH fragment studied for lipolysis in research settings.
Mitochondrial-derived peptide studied in metabolic homeostasis research.
Neuropeptide sometimes discussed for mood, bonding, and intimacy support in provider-directed protocols.
Orally active ghrelin receptor agonist studied for GH/IGF-1 secretion.
Tetrapeptide studied for telomerase activity and circadian rhythm.